ACBM (Acro Biomedical Co) Total Equity: $-0.43 Mil (As of Mar. 2026)


What is Acro Biomedical Co Total Equity?

Acro Biomedical Co ACBM Total Equity is $-0.43 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

Acro Biomedical Co's total equity for the quarter that ended in Mar. 2026 was $-0.43 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Acro Biomedical Co Total Equity Historical Data

* Premium members only.

The historical data trend for Acro Biomedical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acro Biomedical Co Total Equity Chart

Acro Biomedical Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.49 -0.26 -0.30 -0.39

Acro Biomedical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.30 -0.32 -0.43 -0.39 -0.43

Acro Biomedical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Acro Biomedical Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=0.014-0.401
=-0.39

Acro Biomedical Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=0.004-0.431
=-0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-0.43 Mil mean?
Acro Biomedical Co (ACBM) has a Total Equity of $-0.43 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Acro Biomedical Co and its competitors.
Is Acro Biomedical Co's Total Equity too high?
Acro Biomedical Co's current Total Equity is $-0.43 Mil.
How does Acro Biomedical Co's Total Equity compare to RNGC and EEGI?
Acro Biomedical Co's Total Equity of $-0.43 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Diversified Financial Services company?
A good Total Equity depends on the Diversified Financial Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Acro Biomedical Co and its competitors. Acro Biomedical Co's current Total Equity is $-0.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acro Biomedical Co stock overvalued right now?
Acro Biomedical Co (ACBM) has a current Total Equity of $-0.43 Mil. The current Total Equity is $-0.43 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Acro Biomedical Co (ACBM), the current Total Equity is $-0.43 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acro Biomedical Co Business Description

Address 12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd is a shell company.